CX3CR1 and Alzheimer disease: Due to the ability of CX3CL1 to enhance the production of some molecules involved in Aβ degradation, the authors suggested that targeting CX3CL1/CX3CR1 signalling could be considered a useful way to delay the progression of AD by increasing neuronal Aβ clearance and reducing Aβ levels [61].